Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
Taro Pharmaceutical Industries Ltd.

Taro Pharmaceutical Industries Ltd. (TARO) Stock Overview

Explore Taro Pharmaceutical Industries Ltd.’s financial performance, market position, analyst ratings, and future outlook.

TARO●NYSE
HealthcareDrug Manufacturers - Specialty & Generic
$42.98
$0.005(0.01%)
U.S. Market is Open · 13:57

Taro Pharmaceutical Industries Ltd. (TARO)

Meyka AI Score

Z

Key Financials

Market Cap1.6B
P/E Ratio30.05
EPS (TTM)$1.43
ROE0.03%
Fundamental Analysis

AI Price Forecasts

1 MonthN/A
3 MonthsN/A
1 Year Target$43.44

TARO Stock Analysis & Investment Overview (NYSE)

Our AI-powered analysis of Taro Pharmaceutical Industries Ltd. (NYSE: TARO) gives investors deep insight into how the stock performs on the NYSE exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Taro Pharmaceutical Industries Ltd.'s NYSE-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of TARO on the NYSE shows an RSI of N/A, suggesting the stock is in a an undetermined condition. Our forecasting models predict a 12-month price target of $43.44 for the NYSE listing.

Key metrics behind Taro Pharmaceutical Industries Ltd.'s NYSE-traded stock include a P/E ratio of 30.05 and a market capitalization of 1.6B. Combined with our AI analysis, these give both institutional and retail investors a clear view of TARO on the NYSE.

Price Performance (NYSE: TARO)

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
0.01%
3-Month Change
1.72%
6-Month Change
1.50%
Year-to-Date (YTD) Change
2.91%
1-Year Change
13.09%
3-Year Change
-39.10%
5-Year Change
-48.04%
All-Time (Max) Change
22820.00%

Contact Information

https://www.taro.com
972 4 847 5700
14 Hakitor Street, Haifa, NaN, 2624761

Company Facts

15,540 Employees
IPO DateSep 14, 1982
CountryIL

Frequently Asked Questions